Online Only Articles

Granulocyte colony-stimulating factor combined regimen in cord blood transplantation for acute myeloid leukemia: a nationwide retrospective analysis in Japan

Department of Hematology and Oncology, The Institute of Medical Science, The University of Tokyo
Department of Hematology and Oncology, Teikyo University School of Medicine, Tokyo
Department of Hematology, Toranomon Hospital, Tokyo
Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo
Department of Hematology, Kanagawa Cancer Center, Yokohama
Division of Hematology-Oncology, Japanese Red Cross Society Narita Hospital, Narita, Japan
Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai
Department of Hematology, Nippon Medical School, Tokyo
Department of Transfusion Medicine, Tokyo Metropolitan Tama Medical Center, Tokyo
Department of Cell Processing and Transfusion, Research Hospital, The Institute of Medical Science, The University of Tokyo
Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital
Department of HSCT Data Management and Biostatistics, Nagoya University Graduate School of Medicine
Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya;Nagoya University Graduate School of Medicine
Department of Hematology and Oncology, The Institute of Medical Science, The University of Tokyo
System Medical Biology Laboratory, School of Advanced Science and Engineering, Waseda University, Tokyo
Division of Molecular Therapy, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Japan
Vol. 99 No. 12 (2014): December, 2014 https://doi.org/10.3324/haematol.2014.114504